LTRN (Lantern) יחס שווי שוק לשווי בספרים

The price visualization for Lantern Pharma Inc. (LTRN) is based on the implementation of the RADR system, which automates the search for cancer markers via digital modeling instead of manual testing. The current indicator stands at -2.60, while digital sovereignty and cyber threats force the company to allocate significant resources toward data protection. Business stability is maintained through the continuous upgrading of AI cluster capacities, ensuring the uninterrupted operation of the computing infrastructure.

This indicator compares the current market value of Lantern Pharma Inc. (LTRN) with its net assets, combining price volatility and fundamental capital. Investors utilize the P/BV multiple trend to identify business overvaluation relative to its book value. An increase in this metric signals inflated market expectations. For Lantern Pharma Inc. (LTRN), such a premium is justified by its intellectual capital. The company's value is driven not by drug sales, but by the B2B licensing potential of its AI platform.